Regulatory News In Brief
This article was originally published in The Gray Sheet
FDA: Denture adhesives may pose risks
You may also be interested in...
CDRH town halls – 2011 edition
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.